- Home
- CURV vs AURA Comparison
CURV vs AURA Comparison
Compare CURV & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURV
- AURA
- Stock Information
- Founded
- CURV 2001
- AURA 2007
- Country
- CURV United States
- AURA United States
- Employees
- CURV N/A
- AURA N/A
- Industry
- CURV Clothing/Shoe/Accessory Stores
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- CURV Consumer Discretionary
- AURA Health Care
- Exchange
- CURV Nasdaq
- AURA Nasdaq
- Market Cap
- CURV N/A
- AURA 370.1M
- IPO Year
- CURV 2021
- AURA 2021
- Fundamental
- Price
- CURV $5.61
- AURA $7.04
- Analyst Decision
- CURV Hold
- AURA Strong Buy
- Analyst Count
- CURV 4
- AURA 4
- Target Price
- CURV $5.00
- AURA $23.75
- AVG Volume (30 Days)
- CURV 303.7K
- AURA 187.8K
- Earning Date
- CURV 03-20-2025
- AURA 03-24-2025
- Dividend Yield
- CURV N/A
- AURA N/A
- EPS Growth
- CURV 36.36
- AURA N/A
- EPS
- CURV 0.15
- AURA N/A
- Revenue
- CURV $1,103,737,000.00
- AURA N/A
- Revenue This Year
- CURV $1.84
- AURA N/A
- Revenue Next Year
- CURV $1.16
- AURA N/A
- P/E Ratio
- CURV $37.60
- AURA N/A
- Revenue Growth
- CURV N/A
- AURA N/A
- 52 Week Low
- CURV $2.18
- AURA $6.33
- 52 Week High
- CURV $9.14
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- CURV 47.25
- AURA 39.85
- Support Level
- CURV $5.43
- AURA $6.33
- Resistance Level
- CURV $6.95
- AURA $7.73
- Average True Range (ATR)
- CURV 0.46
- AURA 0.36
- MACD
- CURV 0.04
- AURA -0.01
- Stochastic Oscillator
- CURV 39.05
- AURA 52.86
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.